The global skin barrier market size was USD 1.2 Bn in 2022 and is likely to reach USD 1.44 Bn by 2031, expanding at a CAGR of 4.1 % during 2023–2031. The market growth is attributed to the increasing incidence of fecal inconsistency disorders.
Skin barriers are attached to peristomal skin, which protects the skin from stoma output. They are used for patients with fecal incontinence as it helps them to keep the contaminant-free and moisturized skin. Skin barrier products consist of thin film attached to ostomy drainage bags, preventing body fluids leakage.
Skin barrier reduce the transmission of infection by storing body waste in a closed system. Further, it assists with protecting the sacral and perianal pressure areas. These devices play a significant role in minimizing the chances of constipation and involuntary bowel leakage. Skin barrier treatment is increasingly adopted in incontinence, wound care management, and ostomy care.
These devices contain chemicals of humectant or occlusive categories. Some occlusive and water-soluble ingredients include petroleum jelly, zinc oxide, and silicone (dimethicone). Whereas the humectant category includes sorbitol, urea, alpha hydroxy acids, seaweed extracts, and glycerin. Some unique skin barrier recovery products contain ceramides and vitamin B3 additives to facilitate skin barrier regeneration.
The research report finds that the COVID-19 pandemic affected the global skin barrier market. Prolonged usage of facial masks was conditioned for preventing virus contracts. These masks create high humidity levels, which are expected to cause skin damage and concerns.
Skin Barrier Market Dynamics
Major Drivers
Rising adoption of technologically advanced devices for fecal management and an increasing geriatric population is expected to drive the market. Rising incidence of fecal inconsistency disorders, urine incontinence, and irritable bowel syndrome is expected to expand market size and boost product demand. Additionally, the expansion of the healthcare industry and increasing R&D investments by major players toward skin barrier recovery are anticipated to drive the market in the projection period.
Existing Restraints
Lack of experts and skilled professionals and the discomfort caused to patients while using skin barrier products are expected to restrain the market growth. High product cost and lack of patient privacy in using the devices with the help of professionals is expected to affect the market growth. Intimate care activities such as bowel interventions, washing, and toileting can affect the patient’s privacy and result in withdrawal from using the devices. This is further anticipated to hamper the market growth in the coming years.
Emerging Opportunities
Increasing regulations and advancements associated with healthcare in numerous developing countries are projected to create lucrative opportunities in the market. Key players are expanding their regional presence across the globe, which in turn helps in market expansion. Rising cases of autoimmune diseases such as bowel disease require advanced treatments. Thus, research & development investments in such advanced healthcare infrastructure are anticipated to create opportunities in the market in the coming years.
Scope of Skin Barrier Market Report
The report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Skin Barrier Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Shape (Convex and Flat) and Surgery (Urostomy, Colostomy, and Ileostomy)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
3M; Marlen Manufacturing & Development Company; Convatec Group PLC; Hollister Incorporated; SafeGuard Surgical LLC; Cymed; B. Braun SE; Coloplast Corp; Nu-Hope Laboratories, Inc.; and Safe n' Simple
|
Skin Barrier Market Segment Insights
Based on shape, the skin barrier market is bifurcated into convex and flat. The flat segment is expected to expand at a significant growth rate during the projection period, due to the increasing usage of flat shape skin barrier products in attaching ostomy pouches. This is used especially in clinics, hospitals, and home care management in case of fecal inconsistency in adults.
Flat skin barriers consist of a beige floating flange and are utilized in ostomy drainage bags to prevent leakage. They are not made of natural rubber latex and are widely used in the case of bedridden or elderly patients who suffer from irritated bowel systems. These factors fuel the segment of the market in the projection period.
Convex skin barriers segment is projected to register a considerable CAGR in the forecast period, owing to the increasing use in cases of fecal inconsistency. They are made of ceramide material and are available in cut-to-fit applications. Convex skin barrier products are used to match the rigidity of the peristomal plane and abdomen with the available ostomy supplies. They are preferred products for managing flat or retracted stomas and compensating irregular peristomal planes.
On the basis of surgery, the global market is trifurcated into urostomy, colostomy, and ileostomy. The colostomy segment is projected to register a considerable CAGR during the projected period, as the product is highly preferred to manage incontinence. In this surgery type, the surgeon brings an end of the large intestine along the abdominal wall, and one end of the colon is passed through a cut in the abdominal wall, creating a stoma. The Stoma opening is fastened with an ostomy bag which collects waste.
The urostomy segment is expected to contribute to the market revenue in the coming years, as it is widely performed in cases of bladder dysfunction or removal. This surgery is done by creating an opening in the abdominal wall by which urine passes. Colonic conduit and ileal conduit are most common types of fecal inconsistence treatments.
In terms of region, the global skin barrier market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to growing trends in research & development and the rising introduction of bowel-managing devices for fecal management in the region. Rising geriatric population in the region is further boosting the market in the region.
Asia Pacific is expected to grow at a significant rate in the forecast period, due to increasing per capita income in numerous countries of the region. Rising government initiatives for improving the healthcare industry and geographical expansion by key manufacturers result in market growth in the region.
Segments
The skin barrier market has been segmented on the basis of
Shape
Surgery
- Urostomy
- Colostomy
- Ileostomy
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- 3M
- Marlen Manufacturing & Development Company
- Convatec Group PLC
- Hollister Incorporated
- SafeGuard Surgical LLC
- Cymed
- B. Braun SE
- Coloplast Corp
- Nu-Hope Laboratories, Inc.
- Safe n' Simple
Competitive Landscape
Key players operating in the global skin barrier market include 3M; Marlen Manufacturing & Development Company; Convatec Group PLC; Hollister Incorporated; SafeGuard Surgical LLC; Cymed; B. Braun SE; Coloplast Corp; Nu-Hope Laboratories, Inc.; and Safe n' Simple
These companies adopt strategies such as acquisitions, partnerships, certifications, mergers, R&D investments and product launches to boost their market share. For instance,
- On 26 January 2023, Hollister Incorporated was awarded a SURPASS Sole Source Contract for Enterostomal Therapy Products for enterostomal therapy products by Premier, Inc.
- On 20 December 2022, SafeGuard Surgical LLC introduced LeakGuard Biodegradable Stent, a medical-grade and biodegradable stent used to prevent leaks during surgeries. It dissolves over time.
Request For Customization
Enquiry Before Buying
Speak With Analyst
